DiPersio J R, Varga F J, Conwell D L, Kraft J A, Kozak K J, Willis D H
Department of Laboratory Medicine, Christ Hospital, Cincinnati, Ohio 45219.
J Clin Microbiol. 1991 Dec;29(12):2724-30. doi: 10.1128/jcm.29.12.2724-2730.1991.
A rapid (2.5 h) direct enzyme immunoassay (EIA) for Clostridium difficile toxin A was developed for clinical use. Specimen centrifugation and filtration were not required. The EIA detected toxin A levels in patient stool as low as 20 pg (2 ng/ml of stool). The test was 5,000 times more sensitive for toxin A than it was for toxin B and did not react with a panel of other bacterial species with the exception of one highly toxigenic strain of Clostridium sordellii. The EIA was compared with the cytotoxin assay, culture of toxigenic C. difficile (toxigenic culture), and latex agglutination by using 313 fresh stool specimens submitted from patients with suspected C. difficile-associated disease. Results read visually and with a plate reader were similar. Sixty-two specimens were positive by one or more tests, but only 22 (35%) were positive by all four laboratory methods. The EIA was 84.1% sensitive and 98.9% specific when it was compared with the cytotoxin assay. The use of toxigenic culture to referee discrepant results (EIA versus cytotoxin assay) showed the EIA sensitivity and specificity to be 95.1 and 99.3%, respectively, with respect to other laboratory methods. Patient charts were reviewed for antibiotic-associated diarrhea on 108 specimens, including all those that were positive by at least one test method. Of 34 patients determined to have C. difficile-associated disease, 29 (85.3%) were positive by EIA, 32 (94.1%) were positive by the cytotoxin assay, 27 (79.4%) were positive by toxigenic culture, and 20 (58.8%) were positive by latex agglutination. Seven patients with antibiotic-associated diarrhea had a positive latex result, but results were negative by EIA, the cytotoxin assay, and toxigenic culture. The EIA demonstrated high specificity and good sensitivity for C. difficile-associated disease cases. The test can be used alone or in combination with the cytotoxin assay or toxigenic culture to provide rapid and sensitive results.
已开发出一种用于艰难梭菌毒素A的快速(2.5小时)直接酶免疫测定(EIA)法供临床使用。无需对样本进行离心和过滤。该EIA能检测出患者粪便中毒素A的水平低至20皮克(每毫升粪便2纳克)。该检测对毒素A的敏感性比对毒素B高5000倍,除了一株高毒力的索氏梭菌外,不与一组其他细菌发生反应。使用313份疑似艰难梭菌相关疾病患者提交的新鲜粪便标本,将该EIA与细胞毒素检测、产毒艰难梭菌培养(产毒培养)和乳胶凝集试验进行比较。肉眼读取结果和使用酶标仪读取结果相似。62份标本通过一种或多种检测呈阳性,但只有22份(35%)通过所有四种实验室方法均呈阳性。与细胞毒素检测相比,该EIA的敏感性为84.1%,特异性为98.9%。使用产毒培养来判定不一致结果(EIA与细胞毒素检测相比)显示,相对于其他实验室方法,该EIA的敏感性和特异性分别为95.1%和99.3%。对108份标本的患者病历进行了抗生素相关性腹泻审查,包括所有至少通过一种检测方法呈阳性的标本。在34名被判定患有艰难梭菌相关疾病的患者中,29名(85.3%)通过EIA呈阳性,32名(94.1%)通过细胞毒素检测呈阳性,27名(79.4%)通过产毒培养呈阳性,20名(58.8%)通过乳胶凝集试验呈阳性。7名患有抗生素相关性腹泻的患者乳胶检测结果呈阳性,但EIA、细胞毒素检测和产毒培养结果均为阴性。该EIA对艰难梭菌相关疾病病例显示出高特异性和良好的敏感性。该检测可单独使用,或与细胞毒素检测或产毒培养联合使用,以提供快速且敏感的结果。